Readystate Asset Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-2,287
Closed -$403K – 668
2025
Q2
$403K Buy
+2,287
New +$344K 0.01% 447
2025
Q1
– Sell
-6,150
Closed -$776K – 739
2024
Q4
$776K Buy
+6,150
New +$914K 0.02% 419
2024
Q2
– Sell
-9,125
Closed -$959K – 1073
2024
Q1
$959K Sell
9,125
-80,215
-90% -$7.21M 0.01% 713
2023
Q4
$6.75M Buy
89,340
+5,454
+7% +$346K 0.23% 98
2023
Q3
$5.53M Buy
83,886
+26,699
+47% +$2M 0.28% 110
2023
Q2
$4.65M Sell
57,187
-4,381
-7% -$312K 0.35% 82
2023
Q1
$3.66M Buy
61,568
+49,793
+423% +$2.77M 0.34% 90
2022
Q4
$575K Buy
+11,775
New +$544K 0.14% 70

Other funds holding THC

Readystate Asset Management's THC Position: Q3 2025 in Review

Readystate Asset Management sold out of Tenet Healthcare (THC) in Q3 2025, closing a stake of 2,287 shares — an estimated $403K sold.

Readystate Asset Management first reported a position in THC in Q4 2022 and held it in 8 quarters. The position peaked at $6.75M in Q4 2023. 680 funds tracked by Wall St. Rank hold THC as of Q3 2025.

  • Readystate Asset Management reported no remaining Tenet Healthcare position as of Q3 2025 after selling out during the quarter.
  • Readystate Asset Management sold 2,287 Tenet Healthcare shares in Q3 2025, an estimated $403K.
  • Readystate Asset Management first reported a position in Tenet Healthcare in Q4 2022 and held it in 8 quarters.
  • Readystate Asset Management's Tenet Healthcare position peaked at $6.75M in Q4 2023.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2025.

Based on Readystate Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.